This is not the most recent version of the article. View current version (2 OCT 2013)

Intervention Protocol

Beta-2 agonists for exercise induced asthma

  1. Matteo Bonini1,*,
  2. Corrado Di Mambro2,
  3. Moises A Calderon3,
  4. Enrico Compalati1,
  5. Holger Schünemann4,
  6. Stephen Durham5,
  7. Giorgio W Canonica6,
  8. Brian H Rowe7

Editorial Group: Cochrane Airways Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 27 AUG 2008

DOI: 10.1002/14651858.CD003564.pub2


How to Cite

Bonini M, Di Mambro C, Calderon MA, Compalati E, Schünemann H, Durham S, Canonica GW, Rowe BH. Beta-2 agonists for exercise induced asthma (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD003564. DOI: 10.1002/14651858.CD003564.pub2.

Author Information

  1. 1

    University of Genova, Allergy and Respiratory Diseases Clinic, Department of Internal Medicine (DIMI), Genoa, Italy

  2. 2

    Catholic University of Rome, Department of Sport Medicine , Rome , Italy

  3. 3

    Royal Brompton Hospital, Department of Allergy and Respiratory Medicine, London, UK

  4. 4

    National Cancer Institute Regina Elena, INFORMA/CLARITY Research/Department of Epidemiology, Rome, Italy

  5. 5

    Royal Brompton Hospital, Department of Allergy and Respiratory Medicine , London, UK

  6. 6

    University of Genoa, Allergy and Respiratory Diseases Clinic, Department of Internal Medicine (DIMI), Genoa, Italy

  7. 7

    University of Alberta, Department of Emergency Medicine, Edmonton, Alberta, Canada

*Matteo Bonini, Allergy and Respiratory Diseases Clinic, Department of Internal Medicine (DIMI), University of Genova, Genoa, Italy. matte.bonini@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

This is not the most recent version of the article. View current version (02 OCT 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

Aim of this review is to assess the effect of inhaled short- and long-acting beta-2 agonists, compared with placebo, in pre-treatment of EIA.